Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care

Xin Yin,Zhong-de Zhang,Arthur Yin Fan,Xu Zou,Shu-bin Cai,Lan-ting Tao,Lu-ming Chen,Su-hong Xiao
DOI: https://doi.org/10.1016/j.joim.2021.06.001
2021-09-01
Journal of Integrative Medicine
Abstract:<p>There is currently no drug or therapy that can cure the coronavirus disease 2019 (COVID-19), which is highly contagious and can be life-threatening in severe cases. Therefore, seeking potential effective therapies is an urgent task. An older female at the Leishenshan Hospital in Wuhan, China, with a severe case of COVID-19 with significant shortness of breath and decrease in peripheral oxygen saturation (SpO<sub>2</sub>), was treated using manual acupuncture and Chinese herbal medicine granule formula Fuzheng Rescue Lung with Xuebijing Injection in addition to standard care. The patient's breath rate, SpO<sub>2</sub>, heart rate, ratio of neutrophil/lymphocyte (NLR), ratio of monocyte/lymphocyte (MLR), C-reactive protein (CRP), and chest computed tomography were monitored. Acupuncture significantly improved the patient's breathing function, increased SpO<sub>2</sub>, and decreased her heart rate. Chinese herbal medicine might make the effect of acupuncture more stable; the use of herbal medicine also seemed to accelerate the absorption of lung infection lesions when its dosage was increased. The combination of acupuncture and herbs decreased NLR from 14.14 to 5.83, MLR from 1.15 to 0.33 and CRP from 15.25 to 6.01 mg/L. These results indicate that acupuncture and Chinese herbal medicine, as adjuvants to standard care, might achieve better results in treating severe cases of COVID-19.</p>
integrative & complementary medicine
What problem does this paper attempt to address?
The paper aims to address the following issues: 1. **Research Background**: Globally, the COVID-19 pandemic has led to a large number of infections, hospitalizations, and even deaths. Currently, there is no specific drug that can cure this highly contagious and potentially fatal disease. Therefore, finding potentially effective treatments is an urgent task. 2. **Specific Issue**: The paper reports a treatment case of a severe COVID-19 patient. The patient is an 81-year-old female who received treatment at Leishenshan Hospital in Wuhan. She exhibited significant symptoms such as respiratory distress and decreased peripheral blood oxygen saturation (SpO₂). The researchers aim to improve the patient's symptoms by combining acupuncture and traditional Chinese medicine with standard therapy and to evaluate its effectiveness. 3. **Treatment Methods**: - **Acupuncture**: Specific acupoints were used, including Taixi, Metabolic, and Asthma-relieving points, to improve the patient's respiratory function. - **Traditional Chinese Medicine**: Fuzheng Rescue Lung Granules and Xuebijing Injection were used to enhance immune function and accelerate the absorption of lung inflammation. - **Standard Therapy**: Included high-flow oxygen inhalation and antibiotic treatment. 4. **Research Objective**: By combining acupuncture and traditional Chinese medicine, the study aims to evaluate the efficacy of these methods in severe COVID-19 patients and to explore their effects on respiratory function, inflammation markers, and other aspects. In summary, this paper aims to verify the therapeutic effects of acupuncture and traditional Chinese medicine in severe COVID-19 patients through a specific clinical case and to provide a reference for future clinical practice.